Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Kalaris Therapeutics Inc. (KLRS) had Return on Equity of -51.87% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-58.77M |
|
-- |
|
-- |
|
$65.44M |
|
$-65.44M |
|
$6.67M |
|
$-58.77M |
|
$-58.77M |
|
$-58.77M |
|
$-58.77M |
|
$-58.77M |
|
$-58.77M |
|
$-65.44M |
|
$-65.44M |
|
5.01M |
|
5.01M |
|
$-11.73 |
|
$-11.73 |
|
| Balance Sheet Financials | |
$118.55M |
|
-- |
|
-- |
|
$118.55M |
|
$5.24M |
|
-- |
|
-- |
|
$5.24M |
|
$113.31M |
|
$113.31M |
|
$113.31M |
|
5.04M |
|
| Cash Flow Statement Financials | |
$-67.70M |
|
$95.00M |
|
$0.02M |
|
$90.97M |
|
$118.29M |
|
$27.32M |
|
$26.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-67.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-51.87% |
-51.87% |
|
-49.57% |
|
-51.87% |
|
$22.48 |
|
$-13.52 |
|
$-13.52 |
|